Alakananda Dasgupta

Alakananda Dasgupta

Alakananda Dasgupta is a freelance science journalist based in New Delhi, India, who contributes to The Scientist. She is a medical doctor and a pathologist by training. In 2018, she combined her interests in science and writing and became a science writer. She has done research previously in the field of immunology and is currently writing a book on the subject.

Articles by Alakananda Dasgupta
Special Report
The Specter of Endothelial Injury in COVID-19
The Specter of Endothelial Injury in COVID-19
Alakananda Dasgupta | Nov 3, 2020
Studies signal that damage to the endothelium—cells that cover blood vessels like wallpaper—could underpin the thrombosis and inflammation induced by coronavirus infection.
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Alakananda Dasgupta | Sep 15, 2020
A randomized controlled trial on the use of convalescent plasma therapy to treat coronavirus infections—the first in the world to be completed—yields disappointing results, but some doctors are not discouraged.
Is a Bradykinin Storm Brewing in COVID-19?
Is a Bradykinin Storm Brewing in COVID-19?
Alakananda Dasgupta | Aug 26, 2020
Excess of the inflammatory molecule bradykinin may explain the fluid build-up in the lungs of patients with coronavirus infections. Clinical trials of inhibitors are putting this hypothesis to the test.
Infographic: SARS-CoV-2 Interferes with Bradykinin Regulation
Infographic: SARS-CoV-2 Interferes with Bradykinin Regulation
Alakananda Dasgupta | Aug 26, 2020
The leaky blood vessels and lung fluid build-up in some COVID-19 patients might be explained by the virus’s corruption of an inflammation safeguard.
Special Report
Seeking an Early COVID-19 Drug, Researchers Look to Interferons
Seeking an Early COVID-19 Drug, Researchers Look to Interferons
Alakananda Dasgupta | Jul 20, 2020
These antiviral proteins are produced by the body as a natural defense against viral infections and synthetic interferons might help prevent or treat the beginning stages of SARS-CoV-2 infection.
Neutrophil Extracellular Traps May Augur Severe COVID-19
Neutrophil Extracellular Traps May Augur Severe COVID-19
Alakananda Dasgupta | May 28, 2020
These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.
Indian Authorities Propose Use of Homeopathy to Prevent Coronavirus
Indian Authorities Propose Use of Homeopathy to Prevent Coronavirus
Alakananda Dasgupta | Feb 7, 2020
Critics of the practice say the guidance is irresponsible and could give users a false sense of security.
Science in India’s Kashmir Valley in Jeopardy
Science in India’s Kashmir Valley in Jeopardy
Alakananda Dasgupta | Sep 24, 2019
The country’s government has imposed a communication blackout on Jammu and Kashmir, the northernmost region in India, effectively cutting off scientists and students from the rest of the world.